Ivy Foundation Expands Internship Program at TGen

Big News!

             We have expanded our Ivy Neurological Science Internship Program through the Translational Geonomics Research Institute (TGen). This opportunity is known as the premier neuro-related biomedical internship in the state as it offers hands-on biomedical research experience for high school, undergraduate and medical school students. TGen investigators mentor interns interested in the fields of brain tumor research, neuroscience and neurogenomics. They educate the interns about the translational process of moving laboratory discoveries into treatments for patients in clinical trials. “The Ivy Neurological Science Internship Program at TGen has the capacity to inspire a new generation of scientists with the skills needed to pursue the complexities of studying the human brain,” said our president, Catherine Ivy. “As advancements are made in this field, it is ever more important to help guide the next generation of talented individuals who can elevate the research to new levels of discovery – ultimately, the discovery of cures for cancers and neurological disease.”

            Beginning this summer, high-school students will participate in a ten-week program and undergraduates will be able to intern for a full academic year. Additionally, medical students, who are deferring a year of school for research training, will work full-time at TGen. Before now, undergraduates could only intern for one semester and medical students only worked part-time. Our contribution extends the mentoring time available to students in order for them to further develop their bioscience skills under the guidance of the world-class scientific investigators at TGen. “The changes to this year’s Ivy program greatly enhance our efforts to provide hands-on experience for students in the fundamentals of translational research,” said TGen President Dr. Jeffrey Trent. “Through Catherine’s vision and support we are developing a local, highly skilled workforce that will continue to push the boundaries of biomedical research.”

          In addition to brain tumor and neurological sciences laboratory research, Ivy interns gain experience through exposure to clinic life through training, seminars and clinical site tours. The clinical training module will engage them with the ultimate focus of TGen’s investigations — the patients. “Today’s students must be prepared for the rigors of some of the world’s most complex studies in the areas of brain tumor research and neurological sciences,” said Brandy Wells, Manager of TGen’s Education and Outreach program. “The Ivy program provides students with a great preview of what their careers in biomedical research will encompass.”

For more information, please contact Brandy Wells at bwells@tgen.org or 602-343-8655

catherine-ivy-with-tgen-scientists-final

About The Ben & Catherine Ivy Foundation

The Ben & Catherine Ivy Foundation, based in Scottsdale, Ariz., was formed in 2005, when Ben Ivy lost his battle with glioblastoma multiforme (GBM).  Since then, the Foundation has contributed more than $50 million to research in gliomas within the United States and Canada, with the goal of better diagnostics and treatments that offer long-term survival and a high quality of life for patients with brain tumors.  The Ben & Catherine Ivy Foundation is the largest privately funded foundation of its kind in the United States.  For more information, visit www.ivyfoundation.org.  Connect with The Ben & Catherine Ivy Foundation on Facebook at www.facebook.com/IvyFoundation and on Twitter @IvyFoundation.

About TGen

Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit).  TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org.

Congratulations to TGen’s Dr. Bodour Salhia

TGen’s Dr. Bodour Salhia named to 2014 Class of 40 Under 40

Newspaper recognizes TGen cancer researcher among Phoenix’s brightest young leaders

PHOENIX, Ariz. — May 6, 2014 — Dr. Bodour Salhia, a cancer researcher at the Translational Genomics Research Institute (TGen), has been named one of the Phoenix Business Journal’s 2014 Class of 40 Under 40.

Dr. Salhia, an Assistant Professor in TGen’s Integrated Cancer Genomics Division, will be among the 40 up-and-coming Phoenix leaders — less than 40 years of age — at an awards reception June 19 at Phoenix Theater.

In his award notification letter to Dr. Salhia, PBJ Publisher Don Henninger said, “I speak for all the judges in saying that we feel honored to have seen a glimpse of your life and career. You are most certainly a valuable member of our community and a source of inspiration for all.”

All 40 Under 40 classmates will be featured in a special section of the June 20 edition of the PBJ.

“Bodour is a gem; brilliant and transparent. She is an incredible asset to TGen and to the state of Arizona. Watching her growth and career ascent has been one of the highlights of my entire career,” said Dr. John Carpten, TGen Deputy Director of Basic Science.

“She is an amazing scientist, but also frequently participates in patient advocacy and community education,” said Dr. Carpten, also Professor and Director of TGen’s Integrated Cancer Genomics Division. “We are so proud of Bodour. To me, this is not simply a recognition of her achievements, but also a reward for all that she does for others.”

Dr. Salhia, who specializes in researching breast cancer and multiple myeloma, is the fourth TGen staff member in three years to be selected to PBJ’s 40 Under 40. Dr. Matt Huentelman, an Associate Professor in TGen’s Neurogenomics Division, and Dr. Glen Weiss, a Clinical Associate Professor in TGen’s Cancer and Cell Biology Division, were named in 2013. Dr. Candice Nulsen, TGen’s former Director of Education and Community Outreach, was selected in 2012.

“I am so thankful and humbled to be selected among this year’s 40 Under 40 by the Phoenix Business Journal,” said Dr. Salhia, whose community work has included outreach to cancer patients of the Navajo Nation, and service as a board member of Susan G. Komen for the Cure, Central and Northern Arizona Affiliate. “This award is not just about me, but also reflects all the cutting-edge research that TGen conducts, using the human genome to devise better treatments for patients today.”

The 40 Under 40 program’s hundreds of alumni includes Phoenix Mayor Greg Stanton, a member of the TGen Board of Directors, and Arizona Diamondbacks President Derrick Hall, a member of TGen’s National Advisory Council for Pancreatic Cancer Research.

About TGen

Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit).  TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org.